In adults, ScerGAL4Hand.PA drives expression in cardiomyocytes (cardial cells), as well as in pericardial nephrocytes and enterocytes of the gut.
ScerGAL4Hand.PA drives expression in all heart cells (cardioblasts and pericardial cells) from embryonic stage 12.